Life science organizations are confronting a heap of pressure from investors, stakeholders, regulatory experts, patients, and the healthcare industry as they are expected to produce high-quality medical products around the globe. As a result, organizations turn to outsourcing vendors to help them address these constraints. However, their requirements have grown significantly in the last decade as they seek greater scientific knowledge and innovation capabilities than what customary Business Process Organizations (BPOs) or Contract Research Organizations (CROs) are able to offer. Sciformix, a leading scientific knowledge-based organization, is filling the gaps left by these providers to provide a higher level of engagement, quality and value due to its thought leadership, deep domain knowledge, and technology innovation. Founded over a decade ago, Sciformix has been able to successfully provide process, technology, and consulting services to biopharmaceutical, generic pharmaceutical, consumer products, medical devices, and other healthcare companies. Today, Sciformix’s ability to integrate scientific and technology expertise with quality driven processes provides value to its clients throughout the entire drug development cycle. Their clients are gaining an upper hand and are poised to witness greater success and business focus by proactively managing their products with state-of-the-art technology and best-inclass services. Amid its varied range of specialized services, some areas that distinguish Sciformix are Safety & Risk Management, Clinical Development, Regulatory Affairs & Regulatory Operations, Real World Evidence & Market Access, and Technology Services. The company helps clients accelerate their business, drive higher levels of performance and facilitate innovation by employing best-in-class strategies, technologies and expertise.
A Vision that Paved the Way for Growth
The founders of the company—Ajit Nagral, Founder & Chairman, and Chitra Lele, Co-founder & Chief Scientific Officer—had the vision of establishing a company that would provide specialized science-based services to pharmaceutical organizations. Although, the founders initially focused on offerings in Safety & Risk Management and Biometrics, they gradually expanded to include Medical Writing and Regulatory Affairs to support their clients’ growing needs. Soon enough, they introduced Clinical Development, Real World Evidence & Market Access and Technology Services, greatly expanding their offerings and expertise. Headquartered in the US, Sciformix has operations in Europe, India and the Philippines. By employing over 1,000 experts around the world with diverse skill-sets, Sciformix is able to offers its clients flexible and cost-effective deployment models (on-shore, off-shore and hybrid) to meet their unique needs. Sciformix is recognized by the industry for its depth of scientific expertise.
Singularly Dedicated to the Life Science Industry
Through all these years, though, the mission of the Company—to partner with life science companies to provide high quality scientific expertise that delivers better quality outcomes and improved efficiencies across the entire product lifecycle with the ultimate objective of improving quality of healthcare for patients worldwide—hasn’t changed a bit. Since its foundation Sciformix has been singularly dedicated to the life science industry. Therefore, its people, processes, and technologies have been tailored and optimized to meet the industry’s unique needs. Quality, compliance, and scientific excellence are the company’s cornerstones and its experienced subject matter experts (SMEs) and thought leaders are a clear differentiator, enabling Sciformix to provide unique insight and value to its clients. The company delivers consistent quality and compliance across its services by employing scientific rigor in combination with streamlined processes, optimal technology, and efficient people practices. One of the major challenges organizations face today is how to effectively integrate the complexities of two seemingly disparate functions – technology and science – across all phases of the product development life cycle. Typically, outsourcing organizations excel in one or the other, but not both. Sciformix has recognized the synergies of an integrated strategy and unified communication process to help its clients deploy technology for better insight, analytics, and compliance.
Diversification, Growth and Global Reach
Sciformix’s long-term strategy focuses on evolving and enhancing its service and technology offerings, broadening its global reach and growing and diversifying its client and revenue base. This can be seen in the recent launch of several cloud based safety technology service offerings and expansion of its presence in Europe with a new call center operation in Romania. Sciformix is also looking to penetrate underserved markets in Asia Pacific such as South Korea and Taiwan. In addition, the biosimilars market is expected to grow to $20B by 2020 and companies will need Sciformix’s support to enter both established and emerging markets. Sciformix is looking at this market astutely as an area of growth and further expansion.
Meet the CEO
Manish Vinayak Soman, President and CEO of Sciformix has over 26 years of proven experience in overseeing IT operations that encompass program/project management, consulting services, systems development & implementation and business operations; and has managed P&L’s and Balance Sheets for over 15 years. He has held leadership positions across multiple geographies. His past experience includes tenures as CEO & Managing Director of Deloitte India, Global Business Leader for IT at Genpact (formerly a GE company), COO for Patni Computers and Director for BestShore Operations in EMEA for HP Enterprise Services.
Source :- The 10 Most Innovative Pharma and Life Sciences Solutions Providers 2018
